Topic: Mrna Japan

Guest host Maria Z is joined by war correspondent Michael Yon from Yokohama, Japan. Yon reports on the upcoming rollout of "self-replicating mRNA" jabs manufactured in the Fukushima Prefecture. He describes witnessing vaccinations at a baseball stadium and notes that China is reportedly buying up crematoria and funeral home capacity in Japan.

A Japanese study is cited to claim a massive increase in age-adjusted cancer mortality following the third mRNA dose. The discussion explores the theory that spike proteins cause prion-like diseases, such as Creutzfeldt-Jakob or "mad cow disease," and lead to accelerated Alzheimer's. Claims are made that Pfizer vials contain billions of DNA fragments that incorporate into human DNA, causing permanent mutations.

A peer-reviewed study from Japan, discussed by Dr. John Campbell, shows a significant increase in cancer mortality following the third mRNA vaccine dose. Meanwhile, Donald Trump's criminal trial in New York continues, with the former president arguing that his payments to a lawyer were correctly marked as "legal expenses." Trump claims the trial is a Biden-directed effort to keep him off the campaign trail.

Dr. John Campbell highlights a Japanese study titled "Increased Age-Adjusted Cancer Mortality After the Third mRNA Lipid Nanoparticle Vaccine Dose." The research indicates statistically significant increases in ovarian, prostate, and breast cancers, as well as leukemia, in 2022. This data emerged after two-thirds of the Japanese population received booster shots, leading to calls for more open scientific discussion in the West.

A clip from the World Health Summit features a Bayer board member describing mRNA vaccines as an example of cell and gene therapy. Dan Lyman recalls the early hype regarding the extreme cold storage requirements for vaccines, which he contrasts with reports of unlabeled vials and contaminants found in doses in Japan. Shroer and Lyman describe the shifting narrative around mRNA technology as a form of psychological gaslighting.